Advertisement
With the cost of developing and commercializing new drugs at an all-timehigh, there is an acute need for versatile and multitasking analyticalinstruments that can automate routine tasks and obtain more analytical datafaster with a minimum of effort. Waters(R) goal is to allow pharmaceuticalscientists to devote more precious time to value-added, problem-solvingactivities that lie at the heart of the drug discovery process.
Advertisement
Leading Waters' offerings at AAPS is the Xevo(TM) TQ MS System, anadvanced tandem quadrupole mass spectrometer that allows more pharmaceuticalscientists across disciplines to quickly assess the candidacy of promising newentities. Aided by the instrument's IntelliStart(TM) and ScanWave(TM)technologies, the Xevo TQ MS System produces high-quality mass spectral dataat UPLC(R) acquisition speeds without sacrificing data quality. With toolslike the Xevo TQ MS System, increases in information per unit of time -- andin the value of that information -- promise to greatly enhance efforts to"industrialize" the process of drug discovery on a global basis.
Waters Scientific Seminars at AAPS
Waters UPLC and MS technologies have set new standards in resolution,sensitivity and speed of analysis. To demonstrate these capabilities, Waterswill host one-hour educational seminars in Hall 4C, Aisle 100, on thefollowing topics:
Earlier this year the Xevo TQ MS System was recognized by StrategicDirections International's Instrument Business Outlook (IBO) newsletter whenit selected the Xevo TQ MS System as the Best New Product at the 2008 AmericanSociety of Mass Spectrometry (ASMS) annual meeting in June:http://tinyurl.com/5wfehx.
"Since introducing the Xevo TQ MS System four months ago, the feedback wehave received through customer demos has been outstanding," said Brian Smith,Vice President of Mass Spectrometry for the Waters Division. "Ranging from theimpact of an 'intelligent' tandem quadrupole MS that automatically performsall those time consuming optimization steps normally performed manually by askilled MS operator to the novel ScanWave technology that significantlyenhances the quality of spectral data, mass spectrometer users at all levelsare seeing the potential that the Xevo TQ MS System could bring to theirlaboratory."
Waters is now shipping the Xevo TQ MS System to customers on a worldwidebasis.
For More Information
More information on Waters products at AAPS including the Synapt(TM) MSSystem and ACQUITY(R) UPLC System, visit Waters booth #2731 or go to:http://www.waters.com/aaps. For information on the new Xevo TQ MS System visithttp://www.waters.com/xevo. For more information on Waters portfolio of LC/MSproducts, please visit: http://www.waters.com/ms.
About Waters Corporation
Waters Corporation creates business advantages for laboratory-dependentorganizations by delivering practical and sustainable innovation to enablesignificant advancements in such areas as healthcare delivery, environmentalmanagement, food safety, and water quality worldwide.
Pioneering a connected portfolio of separations science, laboratoryinformation management, mass spectrometry and thermal analysis, Waterstechnology breakthroughs and laboratory solutions provide an enduring platformfor customer success.
With revenue of $1.47 billion in 2007 and 5,000 employees, Waters isdriving scientific discovery and operational excellence for customersworldwide.
Waters, Xevo, UltraPerformance LC, UPLC, ACQUITY, Synapt, ScanWave, andIntelliStart are trademarks of Waters Corporation.-- Developing Robust Quantitative Bioanalysis Methods with Innovations in SPE and LC/MS/MS -- High-Sensitivity Qualitative and Quantitative LC/MS: New Possibilities with an Easy-to use Tandem Quadrupole Mass Spectrometer -- An Introduction to UPLC Technology -- An Intelligent UPLC/TOF MS Workflow for Metabolite Identification -- A Simple, Strategic Approach to Method Development -- Maximizing Sensitivity and Flexibility in a Bioanalytical Assay with UPLC/MS
SOURCE Waters Corporation
